Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Blood
|
July 22, 2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease
Corey Cutler, Haesook T Kim, Hassan El Banna, et al.
Blood Advances
|
February 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
The Journal of Clinical Investigation
|
March 29, 2022
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
Roman M Shapiro, Grace C Birch, Guangan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Blood Advances
|
January 26, 2026
Baseline IPSS-M vs Pretransplant Risk Downstaging as Prognostic Determinants in MDS Undergoing Allogeneic Transplantation
Luis E Aguirre, Haesook T Kim, Hany Elmariah, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Blood
|
July 22, 2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease
Corey Cutler, Haesook T Kim, Hassan El Banna, et al.
Blood Advances
|
February 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
The Journal of Clinical Investigation
|
March 29, 2022
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
Roman M Shapiro, Grace C Birch, Guangan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Blood Advances
|
January 26, 2026
Baseline IPSS-M vs Pretransplant Risk Downstaging as Prognostic Determinants in MDS Undergoing Allogeneic Transplantation
Luis E Aguirre, Haesook T Kim, Hany Elmariah, et al.
Page
of 7